Clinical Trials Directory

Trials / Unknown

UnknownNCT02128256

CERAMENT™|G - Bone Healing and Re-infection Prophylaxis

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Dr. Olivier Borens · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The surgical management of long bone infections is often challenging. Adequate surgical debridement decreases the bacterial load, removes dead tissues, and gives a chance for the host immune system and antibiotics to arrest infection. Adequate debridement may leave a large bony defect. An appropriate management of the dead space is essential to arrest the disease, and for maintenance of the bone's integrity. The current strategy includes the use of antibiotic-loaded bone cement that can be used to sterilize and temporarily maintain the dead space. The cement are usually removed after 2 to 4 weeks and replaced with a cancellous graft harvested from the hip of the patient. CERAMENT™\| G is a CE-marked resorbable ceramic bone graft substitute composed by calcium sulfate and calcium hydroxyapatite, intended to fill gaps and voids in the skeleton system and to promote bone healing. The antibiotic gentamicin is included in the ceramic to prevent colonization of gentamicin-sensible microorganisms in order to protect bone healing. The aim of this study is to investigate the device absorption and bone in-growth of CERAMENT™\| G in a surgically revised bone infection. In addition, bone healing and infection non-recurrence will be evaluated during 12 months of follow-up. The investigators expect a treatment success of \>90 % and that a similar bone healing will be obtained as with a standard two-stage surgical procedure. In addition, the investigators believe that the use of CERAMENT™\| G will be of advantage for the patient as bone healing will be achieved with a one-stage surgical procedure (in combination with antibiotic therapy), instead of a two-stage procedure, thus decreasing potential surgery-related complications.

Conditions

Interventions

TypeNameDescription
DEVICECerament G

Timeline

Start date
2014-05-01
Primary completion
2016-05-01
Completion
2017-05-01
First posted
2014-05-01
Last updated
2015-12-02

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02128256. Inclusion in this directory is not an endorsement.